
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Kitasato University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : A study reported that ClO2 denatures the spike protein on the surface of SARS-CoV-2 and inhibits its binding to the human ACE2 receptor of SARS-CoV-2 (COVID-19 Virus), including its Alpha and Gamma variants.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 11, 2021
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Kitasato University
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Stony Brook University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Chlorine Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Mucositis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 08, 2021
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Stony Brook University
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
An Outpatient Study Investigating Non-prescription Treatments for COVID-19
Details : Chlorine Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 09, 2020
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
